Search - tctmd.com

Displaying 541 - 560 of 909

Sort: Relevancy | Date

Presentation

Impact of Gender on Arterial Revascularization Strategies for CABG

September 29, 2017

Presentation iASSESS 2017

New Generation Drug Eluting Stents & Bioabsorbable Vascular Scaffolds: Indications, Outcomes, & Complications

Presenter: Rajesh V. Swaminathan, Dmitriy N. Feldman

August 30, 2017

Presentation CHIP Seattle 2017

Revascularization in Shock: Does it matter?

Presenter: Robert W. Yeh

August 11, 2017

Presentation CHIP Seattle 2017

When to Use Support for Complete Revascularization

Presenter: Ajay J. Kirtane

August 11, 2017

Presentation CHIP Seattle 2017

Inotropes and Drug Therapies for Shock: Data and Outcomes

Presenter: Sunil V. Rao

August 11, 2017

Presentation CHIP Seattle 2017

Unprotected Left Main Stenting and Complete Revascularization

Presenter: Paul Teirstein

August 11, 2017

Presentation CHIP Seattle 2017

The Case for Complete Revascularization

Presenter: Robert F. Riley

August 10, 2017

Presentation CHIP Seattle 2017

Yes, the Data Favor Invasive Management and Revascularization for These Patients (with Ischemic CM)

Presenter: Ajay J. Kirtane

August 10, 2017

Presentation TVT 2017

Management of Stable Coronary Disease in AS Patients: Evolving Treatment Considerations (When to Consider CABG, Timing of PCI With TAVR, and Completeness of Revascularization)

Presenter: Jean-Michel Paradis

June 16, 2017

Early versus Late Revascularization in Patients Hospitalized with Non ST-Segment Elevation Myocardial Infarction: The Atherosclerosis Risk in Communities (ARIC) Surveillance Study

Presentation SCAI 2017

The Atherosclerosis Risk in Communities (ARIC) Surveillance Study

Presenter: Sameer Arora

May 13, 2017

Presentation

FFR-Guided Complete Revascularization in Patients With STEMI and Severe Nonculprit Disease

April 21, 2017

Presentation Fellows 2017

Rationale for Revascularization in Stable Ischemic Heart Disease

Presenter: Sahil A. Parikh, Ajay J. Kirtane

April 08, 2017

Presentation CHIP Washington DC 2017

A Brief Update of PCI for Left Main Disease: Perspectives After the EXCEL and NOBLE Trials

Presenter: Gregg W. Stone

March 21, 2017

Presentation ACC 2017

Randomised Trial of FFR-guided Complete Revascularization versus Infarct Artery only Treatment in Multivessel STEMI Patients

Presenter: Pieter Smits

March 20, 2017

Presentation ACC 2017

iFR vs FFR for Guiding Coronary Revascularization – DEFINE-FLAIR

Presenter: Justin E Davies

March 19, 2017

Presentation CTO 2017

CTO PCI in Patients With Multivessel and Left Main Disease/Concepts of Optimal Revascularization

Presenter: Emmanouil S. Brilakis, Gerald S. Werner, Robert W. Yeh

February 23, 2017

Presentation JIM 2017

Complete Percutaneous Revascularization in a Patient Refused for CABG

Presenter: Marco Ancona

February 11, 2017

Presentation JIM 2017

Hemodynamic Support for Complete Revascularization During the Most Complex Interventions

Presenter: Alaide Chieffo

February 10, 2017

Presentation JIM 2017

CTO and Multi Vessel Disease. The key to complete revascularization

Presenter: Simon Walsh

February 09, 2017

Presentation JIM 2017

Hemodynamic Support for Complete Revascularization in the CTO Setting

Presenter: Jonathan Hill

February 09, 2017

Advertisement

Impact of Gender on Arterial Revascularization Strategies for CABG

New Generation Drug Eluting Stents & Bioabsorbable Vascular Scaffolds: Indications, Outcomes, & Complications

Revascularization in Shock: Does it matter?

When to Use Support for Complete Revascularization

Inotropes and Drug Therapies for Shock: Data and Outcomes

Unprotected Left Main Stenting and Complete Revascularization

The Case for Complete Revascularization

Yes, the Data Favor Invasive Management and Revascularization for These Patients (with Ischemic CM)

Management of Stable Coronary Disease in AS Patients: Evolving Treatment Considerations (When to Consider CABG, Timing of PCI With TAVR, and Completeness of Revascularization)

The Atherosclerosis Risk in Communities (ARIC) Surveillance Study

FFR-Guided Complete Revascularization in Patients With STEMI and Severe Nonculprit Disease

Rationale for Revascularization in Stable Ischemic Heart Disease

A Brief Update of PCI for Left Main Disease: Perspectives After the EXCEL and NOBLE Trials

Randomised Trial of FFR-guided Complete Revascularization versus Infarct Artery only Treatment in Multivessel STEMI Patients

iFR vs FFR for Guiding Coronary Revascularization – DEFINE-FLAIR

CTO PCI in Patients With Multivessel and Left Main Disease/Concepts of Optimal Revascularization

Complete Percutaneous Revascularization in a Patient Refused for CABG

Hemodynamic Support for Complete Revascularization During the Most Complex Interventions

CTO and Multi Vessel Disease. The key to complete revascularization

Hemodynamic Support for Complete Revascularization in the CTO Setting

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content